Literature DB >> 9826193

EPR and CD spectroscopy of fast myosin light chain conformation during binding of trifluoperazine.

W Huang1, G J Wilson, L J Brown, H Lam, B D Hambly.   

Abstract

The conformations of isolated rabbit fast myosin light chains (LCs) were modified using trifluoperazine (TFP), the hydrophobic calmodulin inhibitor. CD spectroscopy showed that TFP altered secondary structural content of the LCs, with half-maximal effects at TFP concentrations of approximately 14-50 microM, which is within the range required to alter muscle fiber contraction in both agonistic and antagonistic ways [Kurebayashi, N. & Ogawa, Y. (1988) J. Physiol. 403, 407-424]. EPR spectroscopy provided structural information from paramagnetic probes on C-terminal domain surfaces. In the absence of TFP, tauR (rotational correlation time) was 1.6 ns for both alkali light chains (ALCs) and 1.8 ns for light chain 2 (LC2). This was faster than expected for proteins of this size (approximately 10 ns). TFP progressively recruited the probes into populations with tauR sevenfold to 12-fold slower, with half-maximal effects at a TFP concentration of approximately 370-800 microM. The differences probably indicate that CD spectroscopy detects changes in protein conformation due to 'specific' TFP binding at the LC hydrophobic core, while less specific binding at higher TFP concentrations is required to effect conformational changes on the protein surfaces near the paramagnetic probes. TFP binding was generally not cooperative. Comparative sequence analysis between calmodulin, troponin C, and myosin LCs indicated considerable conservation between residues expected to bind TFP.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9826193     DOI: 10.1046/j.1432-1327.1998.2570457.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  Response of rigor cross-bridges to stretch detected by fluorescence lifetime imaging microscopy of myosin essential light chain in skeletal muscle fibers.

Authors:  Dmitry S Ushakov; Valentina Caorsi; Delisa Ibanez-Garcia; Hugh B Manning; Antonios D Konitsiotis; Timothy G West; Christopher Dunsby; Paul M French; Michael A Ferenczi
Journal:  J Biol Chem       Date:  2010-11-05       Impact factor: 5.157

2.  Molecular interaction site on procoagulant myosin for factor Xa-dependent prothrombin activation.

Authors:  Hiroshi Deguchi; Zihan Guo; Mohammed Hayat; Elsa Pflimlin; Sam Lear; Weijun Shen; John H Griffin
Journal:  J Biol Chem       Date:  2019-09-03       Impact factor: 5.157

3.  Cardiac Myosin Promotes Thrombin Generation and Coagulation In Vitro and In Vivo.

Authors:  Jevgenia Zilberman-Rudenko; Hiroshi Deguchi; Meenal Shukla; Yoshimasa Oyama; Jennifer N Orje; Zihan Guo; Tine Wyseure; Laurent O Mosnier; Owen J T McCarty; Zaverio M Ruggeri; Tobias Eckle; John H Griffin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-02-27       Impact factor: 8.311

4.  Ca2+-bound calmodulin forms a compact globular structure on binding four trifluoperazine molecules in solution.

Authors:  N Matsushima; N Hayashi; Y Jinbo; Y Izumi
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

5.  Regulatory and essential light chains of myosin rotate equally during contraction of skeletal muscle.

Authors:  Julian Borejdo; Dmitry S Ushakov; Irina Akopova
Journal:  Biophys J       Date:  2002-06       Impact factor: 4.033

6.  Trifluoperazine inhibits the MgATPase activity and in vitro motility of conventional and unconventional myosins.

Authors:  James R Sellers; Fei Wang; Peter D Chantler
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

7.  Interplay of troponin- and Myosin-based pathways of calcium activation in skeletal and cardiac muscle: the use of W7 as an inhibitor of thin filament activation.

Authors:  Bishow B Adhikari; Kuan Wang
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

8.  Novel familial dilated cardiomyopathy mutation in MYL2 affects the structure and function of myosin regulatory light chain.

Authors:  Wenrui Huang; Jingsheng Liang; Chen-Ching Yuan; Katarzyna Kazmierczak; Zhiqun Zhou; Ana Morales; Kim L McBride; Sara M Fitzgerald-Butt; Ray E Hershberger; Danuta Szczesna-Cordary
Journal:  FEBS J       Date:  2015-04-16       Impact factor: 5.542

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.